Rezolute Inc at Jefferies London Healthcare Conference Transcript
My name is Kevin Strang. I'm one of the biotech associates here at Jefferies. It's my pleasure to be here for a fireside chat with Nevan Elam from Rezolute Bio, the Founder and CEO. And yes, thank you for joining us today.
And just to hop into the fireside chat, for those that may be new to the story, could you provide a one-minute intro to Rezolute Bio?
Sure. Thanks, Kevin. And it's a pleasure to be here and to share a little bit of our story here at the conference. At Rezolute Bio we're focused on glucose imbalance, diseases associated with glucose imbalance on a couple of ends of the spectrum. One end of the spectrum is a very rare disease, very problematic pediatric indication where there's not enough glucose that's available for the children at birth. And the disease is congenital hyperinsulinism. It's the overexpression of insulin such that liver fat and muscle uptake glucose and really starve the brain of much-needed glucose.
Serious complications arise
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |